Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 08, 2017
Bioanalytical Systems (BASi) has announced that Philip A. Downing has been promoted to Senior Vice President, Preclinical Services.
read more
Although complexities inherent in biological drug manufacturing are creating barriers for further expansion of the biosimilars market, imminent patent expiries of key biologics are set to create new opportunities for biosimilar manufacturers, ...
read more
Duchesnay, a specialty pharma company with a long-standing commitment to women's health, has acquired exclusive U.S. and Canadian rights to market and distribute Osphena® (ospemifene) from Shionogi Inc. Osphena® is the only oral, non-hormonal ...
read more
Charles River Laboratories International, an early-stage contract research organization (CRO), has extended its longstanding, strategic, integrated drug discovery partnership with Chiesi Farmaceutici SpA in the field of respiratory disease.
read more
New Enterprise Associates, Inc. (NEA) Venture Partner Scott Gottlieb, M.D., has been nominated by President Donald J. Trump to serve as Commissioner of the U.S. Food and Drug Administration (FDA). A physician, policy expert, and champion of health ...
read more
Mylan has agreed to the terms of a global settlement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. in relation to patents for Herceptin® (trastuzumab), which provides Mylan with global licenses for its trastuzumab product.
read more
Heptares Therapeutics, a wholly owned subsidiary of Sosei Group Corporation announced that it has entered into a drug discovery and licensing agreement with Daiichi Sankyo Company, Limited focused on a single G protein-coupled receptor (GPCR) ...
read more
Eurofins Genomics has announced the U.S. commercial launch of a unique DNA synthesis service based on the company's revolutionary next-generation synthesis platform. The service, which is designed to supply small quantities of high-quality oligos for...
read more
Wednesday, March 15, 2017
New product offerings are low endotoxin, multi-compendial grade materials for cell culture and biologic drug formulations. These products extend Roquette's commitment to helping customers save and sustain patient's lives.
read more
Wednesday, March 15, 2017
U.S. District Judge Marcia S. Krieger for the U.S. District Court for Colorado entered a consent decree of permanent injunction against EonNutra LLC, CDSM LLC and HABW LLC, manufacturers and distributors of unapproved drugs and dietary supplements, ...
read more
Wednesday, March 15, 2017
Callery, LLC is the new stand-alone entity formed from BASF's divestment of its Inorganic Specialties business. The divestiture was facilitated by Edgewater Capital in combination with the Callery management team. Callery is a global leader in highly...
read more
Wednesday, March 15, 2017
Envigo announced that it will develop and internally validate five to seven ion channel In vitro tests for measuring cardiac risk potential – ahead of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) recommendations expected at the end of this ...
read more
Wednesday, March 15, 2017
Celerion, a provider of early clinical research solutions, has implemented Verified Clinical Trials (VCT) biometric fingerprint technology to prevent dual enrollment in clinical trials.
read more
Patheon, a global provider of pharmaceutical development and manufacturing services, has reported financial results for the quarter ended January 31, 2017.
read more
Camargo Pharmaceutical Services has received a significant growth investment from a private non-institutional investment firm.
read more